Furthermore, the neuroinflammatory process has been proposed as a potential diagnostic tool through the in vivo evaluation of microglial activation, using DLB imaging with the translocator protein (TSPO) ligand [11C]-PK11195 in FTD and other tauopathies [33,34,35]. This evidence concerns the gene TSPO and frontotemporal dementia.